Skip to main content
. 2021 Apr 3;19(4):203. doi: 10.3390/md19040203

Figure 2.

Figure 2

Electrophoretic mobility of L. vannamei F4 (A) and F5 (B) and reference glycosaminoglycans; heparin, heparan sulphate (HS), dermatan sulphate (DS) and chondroitin sulphate A, C and D (CSA, CSC and CSD, respectively), M = mixture of CSA and heparin.